ARCHIVES

IOM Report Lists Cancer CER Priorities

This article is from The Cancer Letter archive.

Vol. 35 No. 26 | July 3, 2009

Download PDF Visit The Full Archive

Related Articles

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Univ. Of Pennsylvania Ordered to Review all NIH Research

October 11, 1985

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Bennett, Turner & Coleman Law Firm To Merge With Ropes & Gray

July 5, 2002